Skip to content
Longterm Wiki
Back

Credibility Rating

4/5
High(4)

High quality. Established institution or organization with editorial oversight and accountability.

Rating inherited from publication venue: International Biosecurity and Biosafety Initiative

This is a staff profile page for a biosecurity policy professional at IBBIS, relevant to understanding the human expertise behind international DNA synthesis screening standards—a key biosecurity governance mechanism with implications for preventing misuse of synthetic biology.

Metadata

Importance: 28/100homepage

Summary

Profile page for Sophie Peresson, Policy Lead for International Standards at IBBIS, who leads the International Screening Standards initiative for harmonizing biosecurity screening of synthetic nucleic acids globally. She engages with international bodies including IGSC, OECD Synthetic Biology Working Party, and contributes to EU biosecurity policy. Her work sits at the intersection of science, public policy, and health with a focus on synthetic biology governance.

Key Points

  • Technical lead for IBBIS's International Screening Standards initiative, seeking global harmonization of DNA synthesis screening approaches
  • Member of IGSC, OECD Synthetic Biology Working Party, and Pandemic Action Network; former French ISO TC 276 representative
  • Contributed expert input to the ASPR/HHS Screening Framework Guidance revision for synthetic nucleic acid providers
  • Actively contributes to EU Biotech Act and Bioeconomy discussions within the synthetic biology ecosystem
  • Lectures on governance and emerging technologies at Sciences Po; holds degrees from Sorbonne, Johns Hopkins SAIS, and LSHTM

Cited by 1 page

Cached Content Preview

HTTP 200Fetched Mar 20, 20264 KB
- [About](https://ibbis.bio/about/)
  - [People](https://ibbis.bio/about/people/)
  - [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
  - [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
  - [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
  - [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
  - [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
  - [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
  - [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)

[![](https://ibbis.bio/wp-content/themes/ibbis/assets/images/header_logo.png)](https://ibbis.bio/)

- [About](https://ibbis.bio/about/)
  - [People](https://ibbis.bio/about/people/)
  - [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
  - [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
  - [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
  - [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
  - [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
  - [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
  - [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)

Staff

Sophie Peresson

Policy Lead, International Standards

France

[![](https://ibbis.bio/wp-content/themes/ibbis/assets/images/logo_linkedin_blue.svg)](https://www.linkedin.com/in/sophie-peresson/)

Staff

Sophie Peresson

Policy Lead, International Standards

France

[![](https://ibbis.bio/wp-content/themes/ibbis/assets/images/logo_linkedin_blue.svg)](https://www.linkedin.com/in/sophie-peresson/)

Sophie is the technical lead for the International Screening Standards initiative , which seeks to support the harmonization and standardization of screening approaches around the world. She is a member of the International Gene Synthesis Consortium (IGSC), the OECD Synthetic Biology Working Party, Pandemic Action Network (PAN), several other international policy fora and the former French representative at ISO TC 276: Biotechnology working group.

Previously, Sophie played a critical role in the revision of the ASPR/HHS Screening Framework Guidance for providers and users of synthetic nucleic acides, namely by providing expert input on the specific challenges faced by benchtop device manufacturers, and the solutions developed by them. At the EU level, Sophie actively contributes to discussions around the EU Biotech Act and the Bioeconomy, working collaboratively with key stakeholders across the synthetic biology ecosystem. She regularly speaks at international conference

... (truncated, 4 KB total)
Resource ID: 46a7512d24fa065e | Stable ID: Y2UzZTg4OW